ADIPOA2 | Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis
01-01-2015
-31-12-2019
01-01-2015
-31-12-2019
01-04-2020
-31-03-2025
01-04-2016
-30-09-2019
01-09-2017
-31-05-2024
01-12-2018
-31-05-2023
01-06-2016
-30-06-2020
01-02-2023
-31-01-2027
01-05-2017
-31-10-2021
01-02-2025
-31-01-2030
01-02-2021
-31-07-2023
14-02-2020
-13-08-2023
01-01-2016
-30-06-2021
01-01-2020
-31-12-2024
01-09-2017
-28-02-2023
01-05-2015
-31-10-2021
01-07-2022
-30-06-2026
01-11-2022
-31-10-2026
01-01-2024
-31-12-2027
01-11-2020
-31-10-2025
01-01-2016
-31-12-2019
01-01-2020
-31-12-2024
01-05-2015
-31-10-2020
01-01-2019
-30-06-2025
01-10-2022
-30-09-2025
01-02-2023
-31-01-2027
01-01-2015
-31-12-2018
01-01-2025
-31-12-2028
01-01-2017
-31-12-2022
01-06-2021
-31-05-2025
01-11-2022
-31-10-2026